• 提示：詳情請(qǐng)下載說明書。

• 產(chǎn)品描述： Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to atovaquone and parvaquone.

• 靶點(diǎn)： Antibiotic;Parasite

• 體內(nèi)研究：
  Both a hydrous gel and water-in-oil emulsion of buparvaquone significantly reduce cutaneous parasite burden and lesion size than the untreated control. Treatment of N.?caninum infected mice with buparvaquone (100?mg/kg) either by intraperitoneal injection or gavage prevents neosporosis symptoms in 4 out of 6 mice in the intraperitoneally treated group, and in 6 out of 7 mice in the group receiving oral treatment.

• 細(xì)胞實(shí)驗(yàn)： To study whether pretreatment of host cells prior to invasion had any effect on parasite proliferation, confluent HFF grown in 6-well plates are treated with 1μM buparvaquone in medium for 1h or 5h, and controls are exposed to the corresponding amounts of DMSO. Subsequently, the drug-containing medium is removed and monolayers are ished 4 times with Hank's Balanced Salt Solution, and are infected with Nc-Liv tachyzoites in 5mL medium without any drug or solvent. After 2 days, cells are collected with a cell scraper, centrifuged, ished once more in PBS, and the pellet is stored at 20°C prior to quantification of N.caninum proliferation by N.caninum-specific real time PCR as outlined below.

• 動(dòng)物實(shí)驗(yàn)： Mice: On day 0, all mice are infected by intraperitoneal (i.p.) injection of freshly purified N.caninum tachyzoites. After 48h, mice receive BPQ (100mg/kg) as suspension in corn oil either by i.p. injection of a volume of 100μl or by oral application of 100μl by gavage. The control groups obtained the corresponding amount of the solvent only, either i.p. or orally. The treatments are performed 5 times on a daily basis. If not indicated otherwise, mice are inspected twice daily for clinical signs (ruffled coat, apathy, hind limb paralysis) until day 21 post infection (p.i.), at which time they are euthanized.

• 參考文獻(xiàn)：
  1. Reim?o JQ, et al. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi. Exp Parasitol. 2012 Mar;130(3):195-9. 2. Garnier T, et al. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. J Antimicrob Chemother. 2007 Oct;60(4):802-10. 3. Müller J, et al. Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice. Int J Parasitol Drugs Drug Resist. 2015 Feb 13;5(1):16-25.

• 溶解性： Soluble  in  DMSO

• 保存條件： 2-8℃

• 配置溶液濃度參考：
  

  	1mg	5mg	10mg
  1 mM	3.063 ml	15.317 ml	30.634 ml
  5 mM	0.613 ml	3.063 ml	6.127 ml
  10 mM	0.306 ml	1.532 ml	3.063 ml
  50 mM	0.061 ml	0.306 ml	0.613 ml

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

輸入產(chǎn)品批號(hào)：

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *